Joel Greenblatt - Gotham Asset Management
Holding/activity history for Summit Therapeutics Inc. (SMMT)
← All SMMT superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 15,727 | <0.01 | $18.96 | $298,184 | SEC | ||
| 2025 Q4 | 15,727 | <0.01 | $17.49 | $275,065 | SEC | ||
| 2025 Q3 | 15,727 | <0.01 | Reduce 0.01% | $16.31–30.98 · VW $23.62i | $324,920 | SEC | |
| 2025 Q2 | 15,729 | <0.01 | Reduce 0.35% | $15.55–36.91 · VW $22.97i | $334,713 | SEC | |
| 2025 Q1 | 15,785 | <0.01 | $19.29 | $304,493 | SEC | ||
| 2024 Q4 | 15,785 | <0.01 | Reduce 0.77% | $16.52–24.56 · VW $19.49i | $281,683 | SEC | |
| 2024 Q3 | 15,908 | <0.01 | Reduce 18.42% | <0.01 | $6.78–33.89 · VW $19.30i | $348,385 | SEC |
| 2024 Q2 | 19,500 | <0.01 | Buy | <0.01 | $2.10–11.25 · VW $7.18i | $152,100 | SEC |
Price snapshot:
Current price$15.30
Avg. buy price$7.80
+/- since buy96.15%
52-week low$12.55
52-week high$30.98